Jpmorgan Chase & CO BRIDGEBIO PHARMA INC Transaction History

Jpmorgan Chase & CO

44,000

Previous 1,190,000 96.3%

Previous $0 NaN%

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	N/A	-1,146,000 Reduced 96.3%	44,000 $0
Q2 2024 Aug 12, 2024	BUY	N/A	1,190,000 New	1,190,000 $0
Q4 2023 Feb 12, 2024	SELL	N/A	-584,000 Reduced 17.14%	2,824,000 $0
Q3 2023 Nov 14, 2023	BUY	N/A	3,211,000 Added 1629.95%	3,408,000 $0
Q2 2022 Aug 11, 2022	BUY	N/A	2,000 Added 1.03%	197,000 $103,000
Q1 2022 May 11, 2022	SELL	N/A	-3,744,000 Reduced 95.05%	195,000 $115,000
Q4 2021 Feb 10, 2022	BUY	N/A	324,000 Added 8.96%	3,939,000 $2.49 Million
Q3 2021 Nov 12, 2021	BUY	N/A	3,615,000 New	3,615,000 $4.99 Million

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.